Caorsi, R., Lepore, L., Zulian, F., Alessio, M., Stabile, A., Insalaco, A., . . . Gattorno, M. (2013). The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age. BioMed Central.

Caorsi, Roberta, et al. The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven By the Phenotype Severity Rather Than the Age. BioMed Central, 2013.

Caorsi, Roberta, et al. The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven By the Phenotype Severity Rather Than the Age. BioMed Central, 2013.